To compensate for this, we tried to select ATTR-CM exclusively by broadly including cardiac amyloidosis and excluding patients with other cardiac amyloidoses such as AL amyloidosis, AA amyloidosis, and Beta-2-microglobulin amyloidosis. Here, B2M is linked to cardiac amyloidosis.